Septerna Insider Activity: SVP Sells $532K in Pre-Arranged Plan Amid Pipeline Progress
Daniel D. Long, Septerna’s Senior Vice President of Drug Discovery, executed a series of structured equity transactions on June 22, 2026, selling $532,581 in company stock under a Rule 10b5-1 plan. The sale occurred while the stock traded near $36.05, close to its 52-week high of $37.99, following a 237% annual gain. The transactions were part of a…